Events and Networking

Expand Your Network at One of Biocom’s 150+ Annual Events

Biocom Breakfast Meeting: What Precision Medicine Needs to Succeed

When

Thu May 18 14:00:00 GMT 2017 - Thu May 18 16:00:00 GMT 2017

Where

10996 Torreyana Road
San Diego, CA 92121

Register

What Precision Medicine Needs to Succeed:  Collaborations to Deliver Clinical Utility Across the Omics Spectrum

Join us on May 18th as we hear from Corina Shtir, PhD, Head of Precision Medicine at Thermo Fisher Scientific as she discusses how Thermo Fisher Scientific is working on integrating precision medicine solutions across the omics spectrum through collaborations with academia, bio-pharma, clinicians, and the scientific community to revolutionize the way we prevent, detect, treat, and monitor disease.  The integration of a wide range of technologies (cell therapy, next generation sequencing (NGS), genotyping, biobanking, mass spectrometry, synthetic biology, among others) will allow us to better characterize the molecular profile of an individual, and therefore accelerate the development of next generation diagnoses, therapies, and health/disease monitoring.

Following Dr. Shtir's presentation, attendees will have the opportunity to hear a pediatric oncology case study from Timothy Triche, PhD, MD, Children's Hospital of Los Angeles

Cancer in children is fundamentally different than in adults. Diagnosis is often challenging, for lack of tumor-specific morphology, yet treatment is predicated on specific diagnosis. Most patients are treated on standard protocols that require a specific diagnosis, often stratified based on risk. Relapsed patients generally fare poorly, but would likely benefit from genomic analysis of their tumors. We have developed a comprehensive targeted NGS research panel designed specifically to identify genomic features that match existing targeted therapeutic agents. This is the only comprehensive research gene panel for pediatric cancer that encompasses diagnostic, prognostic, and therapeutic targets based on both DNA and RNA in one comprehensive next generation sequencing (NGS) assay.


About Biocom Breakfast Meetings

Utilize your Membership Benefits and attend these Quarterly Member Breakfast events to network with the 100+ attendees ranging from Biocom Board Members and high level CEOs and Executives, to leading scientists, innovators and thought leaders in the industry. Whether you want to learn more about the industry you work in, or if you simply want to network with old friends and colleagues, we hope you join us.  This event is great for folks new to the industry, as well as seasoned pros alike and is intended to help foster the growth of the life sciences community. The Biocom Breakfast Series is a flagship tradition within the San Diego life sciences community. Our breakfast series attract high-caliber, world-class speakers and panelists from across the nation. Breakfast topics address issues that are relevant to the growth and well-being of the life science industry, including economic trends, financing, technology, education and workforce issues.

Check out a sampling of industry companies that will be in attendance at the meeting HERE.


Agenda: 

7:00 am to 7:45 am: High Level Networking 
7:45 am to 8:00 am: Welcome Remarks from Joe Panetta, President & CEO, Biocom
8:00 am to 8:20 am: Corina Shtir, PhD, Head of Precision Medicine, Thermo Fisher Scientific
8:20 am to 9:00 am: Pediatric Oncology Case Study with Timothy Triche, PhD, MD, Children's Hospital Los Angeles


 

Price of Admission

Biocom Member

Today's Price: 45.0

Important Dates

Amount

Registration Before Sat Apr 15 06:59:00 GMT 2017

30.0

Registration Before

Registration Before

Refund after Tue Feb 21 00:00:00 GMT 2017

0.0

Refund after

Refund after

Non-Member (Industry Company Only)

Today's Price: 85.0

Important Dates

Amount

Registration Before Sat Apr 15 06:59:00 GMT 2017

70.0

Registration Before

Registration Before

Refund after Tue Feb 21 00:00:00 GMT 2017

0.0

Refund after

Refund after

  • Industry Attendees

    Abreos Biosciences
    Althea
    Biocept
    Biomatrica
    California State University of San Marcos
    CureMatch Inc.
    EnduRx Pharmaceuticals Inc.
    Evofem Biosciences, Inc
    Ferring Research Institute
    GenomeDx Biosciences
    Illumina, Inc.
    INOVA Diagnostics, Inc.
    J-Labs
    Lexent Bio
    Molecular Assemblies
    Nanomedical Diagnostics
    Nitto BioPharma
    Nitto Denko Technical
    Pfizer Inc.
    PolyPeptide Group
    Prometheus Laboratories
    Regulus Therapeutics
    RIFT Biotherapeutics
    San Diego Blood Bank
    Sanford Burnham Prebys Medical Discovery Institute
    SpectraScience, Inc.
    Thermo Fisher Scientific
    Tracon Pharmaceuticals
    UC San Diego Health
    UCSD Super Computer Center
    USD, University of San Diego
    Valtari Bio
    Xencor
    a0d2A00000BfURgQAN

    Go
  • Industry Attendees

    Abreos Biosciences
    Althea
    Biocept
    Biomatrica
    California State University of San Marcos
    CureMatch Inc.
    EnduRx Pharmaceuticals Inc.
    Evofem Biosciences, Inc
    Ferring Research Institute
    GenomeDx Biosciences
    Illumina, Inc.
    INOVA Diagnostics, Inc.
    J-Labs
    Lexent Bio
    Molecular Assemblies
    Nanomedical Diagnostics
    Nitto BioPharma
    Nitto Denko Technical
    Pfizer Inc.
    PolyPeptide Group
    Prometheus Laboratories
    Regulus Therapeutics
    RIFT Biotherapeutics
    San Diego Blood Bank
    Sanford Burnham Prebys Medical Discovery Institute
    SpectraScience, Inc.
    Thermo Fisher Scientific
    Tracon Pharmaceuticals
    UC San Diego Health
    UCSD Super Computer Center
    USD, University of San Diego
    Valtari Bio
    Xencor

    a0d2A00000BfURgQAN
    Go

Register